Salvatore Lo Vullo

9PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceEpidemiological modellingPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 13, 2022
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers Network.

Giacomo G Baldi, Salvatore Lo Vullo, Giovanni Grignani

|Mar 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).

Claudio Vernieri, Federico Nichetti, Luca Lalli

|Mar 13, 2021
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.

Anna M Frezza, Vinod Ravi, Salvatore Lo Vullo

|Oct 27, 2020
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network.

Silvia Stacchiotti, Noemi Simeone, Salvatore Lo Vullo

|Feb 08, 2020
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life.

Laura D Locati, Donata Galbiati, Giuseppina Calareso

|Sep 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.

Anna Maria Frezza, Tarek Assi, Salvatore Lo Vullo

Pageof 2

Frequent Collaborators

5 joint publications

Silvia Stacchiotti

4 joint publications

Anna Maria Frezza

2 joint publications

Luigi Mariani

2 joint publications

Giovanni Grignani